In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer

Background: Breast cancer is the most common type of cancer worldwide. Cyclin-dependent kinase inhibition is one of the backbones of metastatic breast cancer therapy. However, there are a significant number of therapy failures. This study evaluates the biomarker potential of microRNAs for the predic...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Jasmin Asberger, Kai Berner, Anna Bicker, Marius Metz, Markus Jäger, Daniela Weiß, Clemens Kreutz, Ingolf Juhasz-Böss, Sebastian Mayer, Isabell Ge, Thalia Erbes
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2023-10-01
Serie:	Biomedicines
Soggetti:	microRNAs circulating microRNAs urinary microRNAs CDK inhibitor palbociclib breast cancer
Accesso online:	https://www.mdpi.com/2227-9059/11/10/2705
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!